Overview

Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors

Status:
NOT_YET_RECRUITING

Trial end date:
2026-08-31

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the effect of itraconazole on the pharmacokinetics of HS-20093 in patients with advanced solid tumors.

Phase:

PHASE1

Details

Lead Sponsor:

Hansoh BioMedical R&D Company

Treatments:

Itraconazole